|
Name |
alpha-Sinensal
|
Molecular Formula | C15H22O | |
IUPAC Name* |
(2E,6E,9E)-2,6,10-trimethyldodeca-2,6,9,11-tetraenal
|
|
SMILES |
C/C(=C\C/C=C(\C)/C=C)/CC/C=C(\C)/C=O
|
|
InChI |
InChI=1S/C15H22O/c1-5-13(2)8-6-9-14(3)10-7-11-15(4)12-16/h5,8-9,11-12H,1,6-7,10H2,2-4H3/b13-8+,14-9+,15-11+
|
|
InChIKey |
PFSTYGCNVAVZBK-JQGMZEBDSA-N
|
|
Synonyms |
ALPHA-SINENSAL; 17909-77-2; Sinensal, alpha-; (E,E,E)-2,6,10-Trimethyldodeca-2,6,9,11-tetraen-1-al; 4955-32-2; .alpha.-Sinensal; (2E,6E,9E)-2,6,10-trimethyldodeca-2,6,9,11-tetraenal; 2,6,10-TRIMETHYL-2,6,9,11-DODECATETRAENAL; 2,6,9,11-Dodecatetraenal, 2,6,10-trimethyl-, (2E,6E,9E)-; 5SEZ02PE9O; 2,6,9,11-Dodecatetraenal, 2,6,10-trimethyl-; sinensal (alpha-); EINECS 241-854-6; UNII-5SEZ02PE9O; SCHEMBL713640; DTXSID5063655; CHEBI:10332; DTXSID90884997; (2E,6E,9E)-2,6,10-Trimethyl-2,6,9,11-dodecatetraenal; 2,6,9,11-Dodecatetraenal, 2,6,10-trimethyl-, (E,E,E)-; ZINC4098303; C09729; Q27108620; 2,6,10-Trimethyl-(E,E,E)-2,6,9,11-Dodecatetraenal; (2E,6E,9E)-2,6,10-trimethyl-dodeca-2,6,9,11-tetraenal; 2,6,10-Trimethyl-(2E,6E,9E)-2,6,9,11-Dodecatetraenal
|
|
CAS | 17909-77-2 | |
PubChem CID | 5281534 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 218.33 | ALogp: | 4.8 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 17.1 | Aromatic Rings: | 0 |
Heavy Atoms: | 16 | QED Weighted: | 0.257 |
Caco-2 Permeability: | -4.624 | MDCK Permeability: | 0.00002990 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.017 |
30% Bioavailability (F30%): | 0.002 |
Blood-Brain-Barrier Penetration (BBB): | 0.951 | Plasma Protein Binding (PPB): | 94.97% |
Volume Distribution (VD): | 1.348 | Fu: | 2.43% |
CYP1A2-inhibitor: | 0.409 | CYP1A2-substrate: | 0.762 |
CYP2C19-inhibitor: | 0.455 | CYP2C19-substrate: | 0.816 |
CYP2C9-inhibitor: | 0.232 | CYP2C9-substrate: | 0.974 |
CYP2D6-inhibitor: | 0.18 | CYP2D6-substrate: | 0.9 |
CYP3A4-inhibitor: | 0.179 | CYP3A4-substrate: | 0.164 |
Clearance (CL): | 4.645 | Half-life (T1/2): | 0.845 |
hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.178 |
Drug-inuced Liver Injury (DILI): | 0.015 | AMES Toxicity: | 0.164 |
Rat Oral Acute Toxicity: | 0.015 | Maximum Recommended Daily Dose: | 0.907 |
Skin Sensitization: | 0.955 | Carcinogencity: | 0.423 |
Eye Corrosion: | 0.989 | Eye Irritation: | 0.991 |
Respiratory Toxicity: | 0.969 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001664 | 0.729 | D05XQE | 0.321 | ||||
ENC001564 | 0.729 | D09XWD | 0.317 | ||||
ENC000526 | 0.500 | D03VFL | 0.247 | ||||
ENC001568 | 0.500 | D0H6VY | 0.197 | ||||
ENC001649 | 0.444 | D03ZFG | 0.192 | ||||
ENC001717 | 0.433 | D0S7WX | 0.190 | ||||
ENC002413 | 0.433 | D0M1PQ | 0.190 | ||||
ENC001424 | 0.412 | D0G3PI | 0.186 | ||||
ENC001434 | 0.412 | D02DGU | 0.186 | ||||
ENC001467 | 0.404 | D00DKK | 0.186 |